Sulforaphane Activates Cellular Defense to Protect Skin from UV Damage
Sulforaphane alleviates metabolic disorders and gut microbiota dysbiosis induced by circadian rhythm disruption and a high-fat diet.
The concept of “slow aging” refers to the gradual accumulation of cellular senescence, chronic low-grade inflammation (inflammaging), and oxidative stress over time.
🌱 It is a reasonable assumption that sulforaphane protects the gastrointestinal mucosa from oxidative damage caused by Helicobacter pylori infection and the use of nonsteroidal anti-inflammatory drugs (NSAIDs).
브로콜리, 삶으면 ‘항암 효과’ 다 날아간다? 가장 좋은 조리법은…브로콜리는 미국 국립암연구소(NCI)에서 항암 식품 1위로 꼽을 만큼 항암 효과가 뛰어난 채소로 알려졌다.…health chosun 🌱 Broccoli — A Cancer-Fighting Superfood Broccoli is known as one of the most powerful anticancer vegetables, even ranked No.1 by the U.S. National
This study comprehensively analyzes how sulforaphane prevents cardiovascular diseases (CVDs) through the activation of the Nrf2 signaling pathway.
Recent findings published in Nature Microbiology (2025) report that sulforaphane (SFN) may help improve blood glucose control in individuals with prediabetes.
When reactive oxygen species (ROS) attack our cells, the body activates its natural defense system — the antioxidant pathway. Among the key compounds supporting this defense, sulforaphane has emerged as one of the most powerful.
This review summarizes how sulforaphane (SFN) activates the Nrf2 pathway to suppress inflammation and oxidative stress, thereby supporting immune balance and improving metabolic health. It clearly highlights SFN’s anti-inflammatory and immune-protective effects.
sulforaphane (SFN) may have a positive effect on sleep quality. In particular, participants who consumed glucoraphanin, a precursor of sulforaphane, showed improved sleep quality, increased melatonin levels, and reduced levels of the inflammatory marker prostaglandin D2 (PGD2).
published in Neurochemistry International in October 2024, reports that sulforaphane exhibits significant protective effects against Alzheimer’s-type dementia (AD).